Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families

Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families

Show other versions (1)

Bibliographic Details
Main Authors:	Ludmila Kaplun, Aviva Levine Fridman, Wei Chen, Nancy K. Levin, Sidra Ahsan, Nancie Petrucelli, Jennifer L. Barrick, Robin Gold, Susan Land, Michael S. Simon, Robert T. Morris, Adnan R. Munkarah, Michael A. Tainsky
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-12-01
Series:	Biomarker Insights
Online Access:	http://la-press.com/variants-in-the-signaling-protein-tsad-are-associated-with-susceptibil-a3454

Similar Items

Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families
by: Ludmila Kaplun, et al.
Published: (2012-01-01)

Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.
by: Jaime L Stafford, et al.
Published: (2017-01-01)

Accelerated Tooth Movement and Temporary Skeletal Anchorage Devices (TSADs)
by: Seong-Hun Kim, et al.
Published: (2014-01-01)

KPI-TSAD: A Time-Series Anomaly Detector for KPI Monitoring in Cloud Applications
by: Juan Qiu, et al.
Published: (2019-11-01)

K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review
by: Scott Baughan, et al.
Published: (2021-01-01)

T cell specific adapter protein (TSAd) interacts with Tec kinase ITK to promote CXCL12 induced migration of human and murine T cells.
by: Tone Berge, et al.
Published: (2010-03-01)

Novel TMS for Stroke and Depression (NoTSAD): Accelerated Repetitive Transcranial Magnetic Stimulation as a Safe and Effective Treatment for Post-stroke Depression
by: Jessica Frey, et al.
Published: (2020-08-01)

BRCA1, BRCA2 and primary ovarian insufficiency
by: Zhang Yinuo
Published: (2020-01-01)

Bacillus subtilis YlxR, Which Is Involved in Glucose-Responsive Metabolic Changes, Regulates Expression of tsaD for Protein Quality Control of Pyruvate Dehydrogenase
by: Mitsuo Ogura, et al.
Published: (2019-05-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
by: Tarinee Manchana, et al.
Published: (2020-08-01)

Germline mutations in apoptosis pathway genes in ovarian cancer; the functional role of a TP53I3 (PIG3) variant in ROS production and DNA repair
by: Sophia R. Chaudhry, et al.
Published: (2021-03-01)

The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
by: I A Demidova
Published: (2017-01-01)

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
by: Alena Savanevich, et al.
Published: (2021-01-01)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
by: Roshni D. Kalachand, et al.
Published: (2020-09-01)

BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
by: Fatemeh Keshavarzi, et al.
Published: (2010-01-01)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
by: Kara N. Maxwell, et al.
Published: (2017-08-01)

Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer
by: Madhumita Chatterjee, et al.
Published: (2017-08-01)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
by: Melissa S Cline, et al.
Published: (2018-12-01)

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.
by: Nicolai Juul Birkbak, et al.
Published: (2013-01-01)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01)

BRCA1 and BRCA2 Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families
by: Farid Cherbal, et al.
Published: (2010-01-01)

Genetic modifiers of breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
by: Kuchenbaecker, Karoline Bernhardine Elisabeth Karla Ursula
Published: (2015)

RADIOTHERAPY IN MANAGEMENT OF BRCA-POSITIVE OVARIAN CANCER
by: T. V. Gorodnova, et al.
Published: (2017-09-01)

Clinical features of BRCA-positive ovarian cancer
by: S. Ya. Maximov, et al.
Published: (2016-02-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
by: Ashour M, et al.
Published: (2019-07-01)

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
by: Ewa Przybytkowski, et al.
Published: (2020-03-01)

Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
by: Rachel Mitchell, et al.
Published: (2018-01-01)

Beyond breast and ovarian cancers: PARP inhibitors for BRCA mutation-associated and BRCA-like solid tumors
by: Ciara C. O'Sullivan, et al.
Published: (2014-02-01)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
by: Bielecka Helena, et al.
Published: (2012-01-01)

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland
by: Bielecka Helena, et al.
Published: (2012-04-01)

BRCA1 and BRCA2 Unclassified Variants and Missense Polymorphisms in Algerian Breast/Ovarian Cancer Families
by: Farid Cherbal, et al.
Published: (2012-01-01)

BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.
by: Fabrice Kwiatkowski, et al.
Published: (2015-01-01)

Multianalyte Tests for the Early Detection of Cancer: Speedbumps and Barriers
by: Michael A. Tainsky, et al.
Published: (2007-01-01)

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations
by: Robert L. Hollis, et al.
Published: (2018-01-01)

Ovarian carcinoma in patients with BRCA mutation - a correlation between the growing pattern of peritoneal implants evaluated by CT/MRI and the genotype BRCA1 and BRCA2
by: Ana Catarina Vieira, et al.
Published: (2020-04-01)

Transcriptome Patterns of <i>BRCA1</i>- and <i>BRCA2</i>- Mutated Breast and Ovarian Cancers
by: Arsen Arakelyan, et al.
Published: (2021-01-01)

BRCA1 and BRCA2 Gene Mutations in Breast/Ovarian Cancer Patients from Central and Southern Italy
by: Laura Ottini, et al.
Published: (1999-01-01)

Cannot write session to /tmp/vufind_sessions/sess_c1nn2sovvleq38ft2bd2toju6c